Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 46, No. 2, 2009   

Free Abstract     Article (Fulltext)     Article (PDF 352 KB)     

Free access is sponsored by an educational grant of the European Society for Microcirculation

Research Paper

Peroxisome Proliferator-Activated Receptor Alpha Is Crucial for Iloprost-Induced in vivo Angiogenesis and Vascular Endothelial Growth Factor Upregulation
Federico Biscettia, Eleonora Gaetania, Andrea Flexa, Giuseppe Strafacea, Giovanni Pecorinia, Flavia Angelinia, Egidio Stiglianob, Tamar Aprahamiand, Roy C. Smithe, John J. Castellote, Roberto Polaa, c, e

aLaboratory of Vascular Biology and Genetics, Department of Medicine, A. Gemelli University Hospital and
bDepartment of Pathology, Catholic University School of Medicine, Rome, and
cIRCCS OASI, Troina, Italy;
dMolecular Cardiology, Boston University School of Medicine, and
eDepartment of Anatomy and Cell Biology, Tufts University School of Medicine, Boston, Mass., USA

Address of Corresponding Author

J Vasc Res 2009;46:103-108 (DOI: 10.1159/000143793)


 goto top of page Key Words

  • Iloprost
  • Prostacyclin
  • Peroxisome proliferator-activated receptor-alpha
  • Angiogenesis
  • Vascular endothelial growth factor

 goto top of page Abstract

We have previously demonstrated that iloprost, a stable prostacyclin (PGI2) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (VEGF)-dependent mechanism. In this study, we demonstrate that iloprost-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system. We show that iloprost is unable to induce angiogenesis in mice lacking the PPARalpha gene (PPARalpha-/- mice). Likewise, iloprost-induced VEGF upregulation is absent in PPARalpha-/- mice. In contrast, iloprost induces a robust angiogenic response in wild-type mice, along with local upregulation of VEGF. Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to VEGF, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of iloprost to induce angiogenesis. Our data demonstrate unexpected functional relationships between the PGI2 system and the PPAR signaling pathway and shed new light on the molecular mechanisms involved in iloprost-induced angiogenesis.

Copyright © 2008 S. Karger AG, Basel


 goto top of page Author Contacts

Dr. Roberto Pola
Department of Anatomy and Cell Biology
Tufts University School of Medicine
136 Harrison Avenue, Boston, MA 02111 (USA)
Tel. +1 617 636 0303, Fax +1 617 636 6536, E-Mail roberto.pola@tufts.edu


 goto top of page Article Information

Received: January 18, 2008
Accepted after revision: April 10, 2008
Published online: July 10, 2008
Number of Print Pages : 6
Number of Figures : 4, Number of Tables : 0, Number of References : 17

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18617751)
Download Citation



This journal is part of the second subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2010 S. Karger AG, Basel